Cargando…
Analyses of the combination of 6-MP and dasatinib in cell culture
A major tenet of cancer therapeutics is that combinations of anticancer agents with different mechanisms of action and different toxicities may be effective treatment regimens. Evaluation of additivity/synergy in cell culture may be used to identify drug combination opportunities and to assess risk...
Autores principales: | KAUR, GURMEET, BEHRSING, HOLGER, PARCHMENT, RALPH E., MILLIN, MYRTLE DAVIS, TEICHER, BEVERLY A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742163/ https://www.ncbi.nlm.nih.gov/pubmed/23652925 http://dx.doi.org/10.3892/ijo.2013.1930 |
Ejemplares similares
-
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
por: Beck, Olaf, et al.
Publicado: (2020) -
A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022) -
Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
por: Araujo, John C, et al.
Publicado: (2013) -
Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent
por: Teicher, Beverly A., et al.
Publicado: (2017) -
Dasatinib-Related Chylothorax
por: Huang, Yen-Min, et al.
Publicado: (2015)